Company
SPRUCE BIOSCIENCES, INC. (SPRB)
Standardized SEC financial data for SPRUCE BIOSCIENCES, INC. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001683553 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-100.0%
Return on equity
-91.7%
Free cash flow
-$33.3M
Debt / equity
0.00×
Current ratio
5.17×
EPS (diluted)
$-50.83
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $10.1M | $4.9M | $0 |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $157.4M | $43.0M | $79.1M | $96.4M | $38.8M | $48.9M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$27.5M | $35.9M | $41.7M | $33.3M | $56.0M | -$33.3M |
| Capital expenditures |
Get SPRB data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/SPRB/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/SPRB/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"